Vor BiopharmaVOR
那斯達克 · USD
1.98
-0.04
(-1.98%)
收盤 08/15 03:59 (UTC+8)
盤後
1.96
1.96
(-1.01%)
08/15 03:59 (UTC+8)
Vor BiopharmaVOR
1.98
-0.04
(-1.98%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 0 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 274,284 | 33,291 | 31,311 | 28,513 | 29,035 | - | 28,124 | 35,316 | 32,174 | 30,422 |
研發費用 | 261,499 | 26,701 | 25,348 | 21,817 | 21,823 | 24,322 | 20,897 | 27,606 | 23,897 | 21,915 |
推銷及管理費用 | 12,785 | 6,590 | 5,963 | 6,696 | 7,212 | 8,004 | 7,227 | 7,710 | 8,277 | 8,507 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -274,284 | -33,291 | -31,311 | -28,513 | -29,035 | -32,326 | -28,124 | -35,316 | -32,174 | -30,422 |
其他收入及費用 | - | 805 | 599 | 954 | 1,196 | 1,522 | 1,863 | 2,126 | 2,195 | 1,989 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -1,573,669 | -32,486 | -30,712 | -27,559 | -27,839 | -30,804 | -26,261 | -33,190 | -29,979 | -28,433 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -1,573,669 | -32,486 | -30,712 | -27,559 | -27,839 | -30,804 | -26,261 | -33,190 | -29,979 | -28,433 |
基本每股稅後盈餘(元) | -12.56 | -0.26 | - | -0.40 | -0.41 | -0.45 | - | -0.49 | -0.45 | -0.43 |
稀釋每股稅後盈餘(元) | -12.56 | -0.26 | -0.44 | -0.40 | -0.41 | -0.45 | -0.38 | -0.49 | -0.45 | -0.43 |
基本平均股數(千股) | 125271.00 | 124824.00 | - | 68465.00 | 68299.00 | 68030.00 | - | 67607.00 | 67033.00 | 66265.00 |
稀釋平均股數(千股) | 125271.00 | 124824.00 | - | 68465.00 | 68299.00 | 68030.00 | - | 67607.00 | 67033.00 | 66265.00 |
還原基本每股稅後盈餘(元) | -12.56 | -0.26 | - | -0.40 | -0.41 | -0.45 | - | -0.49 | -0.45 | -0.43 |
還原稀釋每股稅後盈餘(元) | -12.56 | -0.26 | -0.44 | -0.40 | -0.41 | -0.45 | -0.38 | -0.49 | -0.45 | -0.43 |
還原基本平均股數(千股) | 125,271 | 124,824 | - | 68,465 | 68,299 | 68,030 | - | 67,607 | 67,033 | 66,265 |
還原稀釋平均股數(千股) | 125,271 | 124,824 | - | 68,465 | 68,299 | 68,030 | - | 67,607 | 67,033 | 66,265 |
EBITDA(千元) | -1,571,632 | -31,672 | -29,859 | -26,719 | -27,299 | -30,658 | -26,355 | -33,524 | -28,037 | -28,798 |